1. BIO-ARTIFICIAL LIVER (EXTRACORPOREAL TEMPORARY LIVER SUPPORT DEVICES) Alan Golde Jr. BME181 March 18 th 2013

2. The Liver Largest internal organ From 1.2-1.6kg (3.2-3.7lb) Hepatic cells (hepatocytes) responsible for liver functions Make up 80% of the liver Liver is responsible for up to 500 separate functions Removing/excreting body wastes and hormones as well as drugs and other foreign substances Synthesizing plasma proteins, including those necessary for blood clotting Helping the body fight infection Producing bile to aid in digestion Storing certain vitamins, minerals, and sugars Regenerative Restoration of function not original form

3. Complications Most common causes of liver failure hepatitis A,B,C,D,E Alcohol damage Fatty liver Cirrhosis Cancer and drug damage

4. Treatments Liver Transplant Pros Most effective treatment for acute liver failure High survival rates Cons Scarcity of donors Reduced clotting factors Immunosuppressant's increase risk for infection Rejection Bio-artificial Liver Pros Keep the patient alive until transplant is available Aid in the livers regeneration Cons Are only a temporary fix

5. Current Work in BAL’s Molecular Absorbent Recycling System (MARS®) Teraklin, uses human albumin Extracorporeal Liver Assist Device (ELAD®) Vitagen, uses immortalized human hepatocytes HepatAssist 2000 system Circe Biomedical, uses porcine hepatocytes Bioartificial Liver Support System (BLSS®) Excorp Medical, Inc., uses primary porcine hepatocytes LIVERX2000 system Algenix, Inc., uses porcine hepatocytes Modular Extracorporeal Liver System (MELS®) Charite Virchow Clinic-Berlin, uses human hepatocytes

7. Bio Engines Implantable Device Designed to take place of a liver or a portion of the liver Polymer grid-like mesh used as artificial vasculature resembling that of an actual liver Patterned silicon wafers serve as molds for polymer sheets Currently being tested on pigs Clotting issues

8. Challenges Bio-artificial livers should be able to provide at least 10% of liver functioning This requires approximately 10 10 hepatocytes Very difficult acquiring this many hepatocyte cells Controversy over the use of porcine cells due to possible transmission of infections Hepatocytes and plasma have very different physio-chemical properties Hepatocytes do not perform well when in contact with plasma Have a very high oxygen uptake rate Hepatocyte cells undergo a lot of stress inside of bio-artificial liver Any stress above 5 dyn/cm 2 renders cells useless Limited volume of the bioreactor maximum blood/plasma that can be safely drawn out of liver failure patient is one liter Difficult to achieve 10% of liver functioning within 1 liter Makes Bio-artificial liver designing very difficult

9. Future Research in: Cell sources Bioreactor design Filtering techniques Packaging for implantable devices

10. Sources http://biomed.brown.edu/Courses/BI108/BI108_2002_Groups/liver/we bpage/intro.html http://biomed.brown.edu/Courses/BI108/BI108_2002_Groups/liver/we bpage/intro.html Palakkan, A. A., Hay, D. C., PR, A. K., TV, K. and Ross, J. A. (2013), Liver tissue engineering and cell sources: issues and challenges. Liver International. doi: 10.1111/liv.12134 http://www.xconomy.com/boston/2007/09/20/bioengine-one-step- closer-to-artificial-liver-device/ http://www.xconomy.com/boston/2007/09/20/bioengine-one-step- closer-to-artificial-liver-device/ http://nyp.org/news/hospital/artificial-liver-lives.html http://artificial-liver.blogspot.com/2009/11/biological-extracorporeal- liver-assist.html http://artificial-liver.blogspot.com/2009/11/biological-extracorporeal- liver-assist.html